Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenocarcinoma Pancreas × Gastrointestinal × Clear all

Phase

Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 97 Carcinoma, Hepatocellular 93 Stomach Neoplasms 57 Pancreatic Neoplasms 43 Liver Neoplasms 35 Colonic Neoplasms 32 Esophageal Neoplasms 26 Rectal Neoplasms 18 Neoplasms 11 Barrett Esophagus 11 Recurrence 10 Neoplasm Metastasis 10 Gastrointestinal Stromal Tumors 9 Gastrointestinal Neoplasms 9 Breast Neoplasms 9 Bile Duct Neoplasms 9 Pain, Postoperative 8 Lung Neoplasms 6 Head and Neck Neoplasms 6 Cholangiocarcinoma 6 Agnosia 6 Adenocarcinoma 6 Prostatic Neoplasms 5 Postoperative Complications 5 Peptic Ulcer 5 Pain 5 Hepatitis B 5 Gastritis 5 Fibrosis 5 Dyspepsia 5

Interventions

Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02812992 2021-08-10

GrantPax

AIO-Studien-gGmbH

Phase 4 Completed

Gastrointestinal

Adenocarcinoma Pancreas

Data powered by HemOnc (CC BY 4.0) Colophon ⚡